Shorter Surgery Gap, Better Outcomes: New Insights into Immunochemotherapy for Esophageal Cancer A Look into New Treatment Strategies for a Difficult Disease Esophageal cancer (EC) is among the most aggressive and deadly cancers worldwide. It […]
Esophageal cancer (EC) is the eighth most common cancer and the sixth leading cause of cancer death globally. In 2020, there were 324000 new cases and 301000 related deaths of esophageal cancer in China, accounting […]
Kaposi sarcoma (KS) is a rare disease, and there is no specific treatment protocol agreed upon, especially for the classical type. Chemotherapeutics such as paclitaxel, pegylated liposomal doxorubicin (PLD), etoposide, gemcitabine are used in the […]
Acute promyelocytic leukemia (APL) is a special subclassification of acute myeloid leukemia (AML) with a favorable clinical outcome. The typical karyotype of APL is the translocation of chromosomes 15 and 17, which is described as […]
Copyright (c) 2021 Association of Basic Medical Sciences of FBIH